Literature DB >> 32841154

Mycophenolate Mofetil Treatment of C3 Glomerulopathy.

Yonatan Peleg1, Gerald B Appel2.   

Abstract

Entities:  

Keywords:  mycophenolate mofetil

Year:  2020        PMID： 32841154      PMCID： PMC7480544          DOI： 10.2215/CJN.11740720

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  10 in total

Review 1.  C3 Glomerulopathy: Pathogenesis and Treatment.

Authors:  Syeda Behjat Ahmad; Andrew S Bomback
Journal:  Adv Chronic Kidney Dis       Date:  2020-03       Impact factor: 3.620

2.  C3 glomerulonephritis and dense deposit disease share a similar disease course in a large United States cohort of patients with C3 glomerulopathy.

Authors:  Andrew S Bomback; Dominick Santoriello; Rupali S Avasare; Renu Regunathan-Shenk; Pietro A Canetta; Wooin Ahn; Jai Radhakrishnan; Maddalena Marasa; Paul E Rosenstiel; Leal C Herlitz; Glen S Markowitz; Vivette D D'Agati; Gerald B Appel
Journal:  Kidney Int       Date:  2018-01-06       Impact factor: 10.612

3.  Patterns of Clinical Response to Eculizumab in Patients With C3 Glomerulopathy.

Authors:  Moglie Le Quintrec; Anne-Laure Lapeyraque; Arnaud Lionet; Anne-Laure Sellier-Leclerc; Yahsou Delmas; Véronique Baudouin; Eric Daugas; Stéphane Decramer; Leila Tricot; Mathilde Cailliez; Philippe Dubot; Aude Servais; Catherine Mourey-Epron; Franck Pourcine; Chantal Loirat; Véronique Frémeaux-Bacchi; Fadi Fakhouri
Journal:  Am J Kidney Dis       Date:  2018-02-09       Impact factor: 8.860

4.  Mycophenolate Mofetil in Combination with Steroids for Treatment of C3 Glomerulopathy: A Case Series.

Authors:  Rupali S Avasare; Pietro A Canetta; Andrew S Bomback; Maddalena Marasa; Yasar Caliskan; Yasemin Ozluk; Yifu Li; Ali G Gharavi; Gerald B Appel
Journal:  Clin J Am Soc Nephrol       Date:  2018-01-11       Impact factor: 8.237

Review 5.  C3 glomerulopathy - understanding a rare complement-driven renal disease.

Authors:  Richard J H Smith; Gerald B Appel; Anna M Blom; H Terence Cook; Vivette D D'Agati; Fadi Fakhouri; Véronique Fremeaux-Bacchi; Mihály Józsi; David Kavanagh; John D Lambris; Marina Noris; Matthew C Pickering; Giuseppe Remuzzi; Santiago Rodriguez de Córdoba; Sanjeev Sethi; Johan Van der Vlag; Peter F Zipfel; Carla M Nester
Journal:  Nat Rev Nephrol       Date:  2019-03       Impact factor: 28.314

6.  Pathology after eculizumab in dense deposit disease and C3 GN.

Authors:  Leal C Herlitz; Andrew S Bomback; Glen S Markowitz; M Barry Stokes; R Neal Smith; Robert B Colvin; Gerald B Appel; Vivette D D'Agati
Journal:  J Am Soc Nephrol       Date:  2012-06-07       Impact factor: 10.121

7.  C3 glomerulopathy associated with monoclonal Ig is a distinct subtype.

Authors:  Aishwarya Ravindran; Fernando C Fervenza; Richard J H Smith; Sanjeev Sethi
Journal:  Kidney Int       Date:  2018-05-03       Impact factor: 10.612

8.  C3 Glomerulopathy: Ten Years' Experience at Mayo Clinic.

Authors:  Aishwarya Ravindran; Fernando C Fervenza; Richard J H Smith; An S De Vriese; Sanjeev Sethi
Journal:  Mayo Clin Proc       Date:  2018-08       Impact factor: 7.616

9.  Effectiveness of mycophenolate mofetil in C3 glomerulonephritis.

Authors:  Cristina Rabasco; Teresa Cavero; Elena Román; Jorge Rojas-Rivera; Teresa Olea; Mario Espinosa; Virginia Cabello; Gema Fernández-Juarez; Fayna González; Ana Ávila; José María Baltar; Montserrat Díaz; Raquel Alegre; Sandra Elías; Monserrat Antón; Miguel Angel Frutos; Alfonso Pobes; Miguel Blasco; Francisco Martín; Carmen Bernis; Manuel Macías; Sergio Barroso; Alberto de Lorenzo; Gema Ariceta; Manuel López-Mendoza; Begoña Rivas; Katia López-Revuelta; José María Campistol; Santiago Mendizábal; Santiago Rodríguez de Córdoba; Manuel Praga
Journal:  Kidney Int       Date:  2015-07-29       Impact factor: 10.612

10.  Mycophenolate Mofetil in C3 Glomerulopathy and Pathogenic Drivers of the Disease.

Authors:  Fernando Caravaca-Fontán; Montserrat M Díaz-Encarnación; Laura Lucientes; Teresa Cavero; Virginia Cabello; Gema Ariceta; Luis F Quintana; Helena Marco; Xoana Barros; Natalia Ramos; Nuria Rodríguez-Mendiola; Sonia Cruz; Gema Fernández-Juárez; Adela Rodríguez; Ana Pérez de José; Cristina Rabasco; Raquel Rodado; Loreto Fernández; Vanessa Pérez Gómez; Ana I Ávila; Luis Bravo; Javier Lumbreras; Natalia Allende; Maria Dolores Sanchez de la Nieta; Eva Rodríguez; Teresa Olea; Marta Melgosa; Ana Huerta; Rosa Miquel; Carmen Mon; Gloria Fraga; Alberto de Lorenzo; Juliana Draibe; Marta Cano-Megías; Fayna González; Amir Shabaka; Maria Esperanza López-Rubio; María Ángeles Fenollosa; Luis Martín-Penagos; Iara Da Silva; Juana Alonso Titos; Santiago Rodríguez de Córdoba; Elena Goicoechea de Jorge; Manuel Praga
Journal:  Clin J Am Soc Nephrol       Date:  2020-08-19       Impact factor: 8.237
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.